Overview

A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT

Status:
Unknown status
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Improvement of quality of life in patients with BO and establishment of a new third line therapy
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital Regensburg
Collaborator:
ClinAssess GmbH
Treatments:
Interferon-gamma
Interferons